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I In nt tr ro od du uc ct ti io on n
Aortic valvular stenosis (AVS) is a chronic and progressive
disease. According to previous study in Western population,
it has been shown that the rate of aortic jet velocity progres-
sion is approximately 0.3 meter/second/year (m/s/yr), the
aortic valve area (AVA) decreases by 0.1 cm
2/yr and the mean
gradient increases by 7 to 8 mmHg/yr.
1-4) Also, the rate of
hemodynamic progression is associated with the severity of
AVS, old age, valve calcification, and concurrent coronary
artery disease.
3-6)
Recently, it has been reported that there was ethnic differ-
ences in aortic valve (AV) thickness and calcification
7)8)
which may play a role in AVS progression. However, the
study of the progression rate of AVS in the Korean popula-
tion is rare.
9) Therefore, the present study was performed to
evaluate the progression rate of AVS in Korean patients and
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B Ba ac ck kg gr ro ou un nd d: : Although there were studies about ethnic differences in aortic valve thickness and calcification that they may
play a role in aortic valvular stenosis (AVS) progression, few studies about the progression rate of AVS in Asian population
have been reported. The purpose of this study was to evaluate the progression rate of AVS in Korean patients.
M Me et th ho od ds s: : We retrospectively analyzed 325 patients (181 men, age: 67 ± 13 years) with AVS who had 2 or more
echocardiograms at least 6 months apart from 2003 to 2008. The patients with other significant valvular diseases or history of
cardiac surgery were excluded. The progression rate of AVS was expressed in terms of increase in maximum aortic jet velocity
per year (meter/second/year).
R Re es su ul lt ts s: : Baseline AVS was mild in 207 (64%), moderate in 81 (25%), and severe in 37 (11%). There were no significant
differences among the three groups in terms of age, gender, hypertension, smoking, and hypercholesterolemia. The mean
progression rate was 0.12 ± 0.23 m/s/yr and more rapid in severe AVS (0.28 ± 0.36 m/s/yr) when compared to moderate
(0.14 ± 0.26 m/s/yr) and mild AVS (0.09 ± 0.18 m/s/yr) (p < 0.001). The progression rate in bicuspid AVS was significantly
higher than other AVS (0.23 ± 0.35 vs. 0.11 ± 0.20 m/s/yr, p = 0.002). By multivariate analysis, initial maximum aortic jet
velocity (Beta = 0.175, p = 0.003), bicuspid aortic valve (Beta = 0.127, p = 0.029), and E velocity (Beta = -0.134, p = 0.018)
were significantly associated with AVS progression.
C Co on nc cl lu us si io on n: : The progression rate of AVS in Korean patients is slower than that reported in Western population. Therefore,
ethnic difference should be considered for the follow-up of the patients with AVS.
KEY WORDS: Aortic valvular stenosis∙Natural history∙Disease progression.
online © ML Commto determine clinical, echocardiographic, and biochemical
characteristics that may have a bearing on the progression of
this common clinical problem.
M Me et th ho od ds s
Study population
We retrospectively analyzed echocardiograms of all patients
with AVS diagnosed by 2-D and Doppler echocardiography,
and selected patients who had at least 2 echocardiography
examinations at intervals of 6 months or longer apart from
2003 to 2008. Initially, 541 patients were enrolled. Exclusion
criteria were the presense of other significant valvular disease,
left ventricular systolic dysfunction (left ventricular ejection
fraction < 40%), congenital heart disease, cardiomyopathy,
permanent pacemaker, uncontrolled tachycardia or brady-
cardia, and history of cardiac surgery. Finally, 326 out of
total 541 patients were included in this study.
Clinical data including past medical history and presence
of risk factors were obtained by complete review of each
patient’s medical record and laboratory findings. The pre-
sence of hypercholesterolemia (total cholesterol > 200
mg/dL or patients on lipid lowering therapy), diabetes melli-
tus (fasting plasma glucose > 126, plasma glucose level (any-
time) > 200 mg/dL, or patients on antidiabetic medication),
hypertension (blood pressure ≥ 140/90 mm Hg or patients
on anti-hypertensive medication) and coronary artery disease
(documented previous myocardial infarction or angiographi-
cally documented coronary artery stenosis more than 50%
in luminal diameter) were recorded.
This study was approved by the institutional ethical review
board.
Echocardiography
Comprehensive transthoracic echocardiography was per-
formed by commercially available equipments (Vivid 7, GE
Medical system, Milwaukee, WI or Acuson 512, Siemens
Medical Solution, Mountain View, CA or Sonos 5500,
Philips Medical System, Andover, MA, USA). Standard M-
mode, 2-D and color Doppler imaging were performed in
parasternal, suprasternal, substernal, and apical views with
the positional change of the patients. The first and last echo-
cardiograms taken during the study period were used to eval-
uate the echocardiographic changes. Anatomic measure-
ments were made according to ASE guideline.
10) Left ventri-
cular (LV) mass was calculated using the Devereux-modified
formula
11): LV mass = 0.8 {1.04 [(LVEDD + LVPW + IVS)
3-
LVEDD
3]}+0.6. LV mass index (LVMI) was calculated from
LV mass divided by body surface area (m
2). AVA was mea-
sured using the continuity equation.
12) AVS severity was grad-
ed on the basis of a variety of hemodynamic data, using
maximum aortic jet velocity, mean pressure gradients, and
valve area.
10) The progression rate in those subjects was
expressed by increase of maximum aortic jet velocity per year
(m/s/yr). A bicuspid aortic valve (BAV) was diagnosed if
only 2 leaflets were present and the commissures were in
locations different from those of a normal tricuspid valve.
Statistical analysis
Continuous variables are listed as mean  ± standard devia-
tion (SD). Because a mean increase in maximum aortic jet
velocity per year is 0.12 m/s, the patients were dichotomo-
usly divided into rapid (≥ 0.12 m/s/yr) and slow progressors
(< 0.12 m/s/yr). Mean values were compared by the unpair-
ed t test or ANOVA. Kruskall-Wallis test was used when the
variances of the groups being compared were unequal. Cate-
gorical variables are presented as frequencies or group per-
centages. Differences in categorical variables were analyzed
by Chi-square test or Fisher’s exact test. Correlations were
evaluated with Pearson’s correlation coefficient. Stepwise
multiple linear regression analysis was used to identify the
factors which were associated with AVS progression. A p
value of < 0.05 was considered statistically significant. All
statistical analyses were performed using SPSS 15.0 for
Windows (SPSS Inc., Chicago, IL, USA).
R Re es su ul lt ts s
Baseline patients characteristics
Of the 325 patients, 181 (55%) were men. Their mean
age was 67 ± 13 years. The mean value of initial maximum
aortic jet velocity in total patients was 2.92 ± 0.81 m/s. The
AVS was mild in 207 of 326 patients (63%), moderate in 81
(25%), and severe in 37 (12%). One hundred ninety three
patients (59%) had hypertension, 93 (29%) were dia-betics,
53 (17%) were current smokers, and 144 (45%) had
hypercholesterolemia. There were no significant differences
among the three groups in terms of age, gender, hyperten-
sion, smoking, and hypercholesterolemia. The LVMI was
larger in severe AVS (125.4 ± 34.5 g/m
2) compared to mo-
derate (121.7 ± 34.1 g/m
2) and mild (111.6 ± 32.3 g/m
2) (p
= 0.013). BAV was present in 41 (13%) and more frequent
in severe AVS than in moderate and mild AVS (32% vs. 19%
vs. 7%, p < 0.001). Table 1 and 2 show initial clinical and
echocardiographic characteristics in each group, respectively.
Progression rate of aortic valvular stenosis
The mean interval of the echocardiographic studies was 28
± 13 months. Over this period of time, the maximum aortic
jet velocity increased from 2.92  ± 0.81 to 3.19 ± 0.99 m/s
and the annual progression rate of maximum aortic jet velo-
city was 0.12 ± 0.23 m/s/yr, indicating a wide variability in
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128AVS progression. The annual progression rate was more
rapid in severe AVS (0.28 ± 0.36 m/s/yr) compared to mo-
derate (0.14 ± 0.25 m/s/yr) and mild AVS (0.09 ± 0.18
m/s/yr) (p < 0.001) (Fig. 1). The progression rate in bicuspid
AVS was significantly higher than that of tricuspid AVS
(0.23 ±0.35 vs. 0.11 ±0.20 m/s/yr, p= 0.001) (Fig. 2). 
Comparison of rapid and slow progressors
At a mean increase in maximum aortic jet velocity per year
of 0.12 m/s, the patients were dichotomously divided into
rapid (≥ 0.12 m/s/yr) and slow progressors (< 0.12 m/s/yr).
As shown in Table 3, the rapid progressor had higher initial
maximum aortic jet velocity (p = 0.002), higher mean trans-
valvular gradient (p < 0.001), smaller AVA (p = 0.007), and
lower E velocity (p= 0.018).
Multiple regression analysis for factors 
associated with AVS progression
A stepwise multiple regression analysis was carried out to
identify the factors which were associated with the increase
in maximum aortic jet velocity per year. In univariate analysis,
the progression rate of AVS was significantly related to BAV,
creatinine, initial maximum aortic jet velocity, LV end-dias-
tolic dimension, left atrial dimension, and E velocity. All
variables with a p-value < 0.10 in the univariate analysis were
entered in the model. Annual progression rate was indepen-
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Table 1. Clinical characteristics
Mild AVS (n = 207) Moderate AVS (n = 81) Severe AVS (n = 37) p value
Age (yr) 67  ± 12 67  ± 14 65  ± 12 0.794
Gender (male) 114 (55.1%) 43 (53.1%) 24 (64.9%) 0.468
BMI (kg/m
2) 24.8  ± 3.7 23.7  ± 3.4 24.7  ± 3.8 0.071
SBP (mmHg) 137.5  ± 22.9 135.7  ± 25.9 129.3  ± 20.0 0.144
DBP (mmHg) 76.1  ± 13.3 75.7  ± 14.1 74.8  ± 11.9 0.846
Current smoking 32 (15.6%) 14 (18.2%) 7 (28.9%) 0.807
Hypertension 123 (59.4%) 51 (63.0%) 19 (51.4%) 0.492
Diabetes 60 (29.0%) 27 (33.3%) 6 (16.2%) 0.159
Hypercholesterolemia 102 (49.5%) 28 (36.8%) 14 (38.9%) 0.118
Coronary artery disease 52 (25.1%) 15 (18.5%) 4 (10.8%) 0.107
Total cholesterol (mg/dL) 176.7  ± 40.1 168.2  ± 36.9 171.5  ± 34.6 0.247
LDL-cholesterol (mg/dL) 113.0  ± 37.2 107.2  ± 34.2 109.8  ± 32.0 0.528
HDL-cholesterol (mg/dL) 47.5  ± 14.8 46.0  ± 12.6 47.6  ± 13.0 0.759
Triglyceride (mg/dL) 127.2  ± 71.2 125.1  ± 69.1 109.9  ± 55.7 0.409
Glucose (mg/dL) 124.1  ± 59.5 123.7  ± 58.2 107.2  ± 23.9 0.244
Calcium (mg/dL) 9.0  ± 0.6 8.8  ± 0.7 9.2  ± 0.8 0.060
Uric acid (mg/dL) 5.4  ± 1.8 5.5  ± 1.7 5.6  ± 1.5 0.787
Creatinine (mg/dL) 1.5  ± 2.0 1.5  ± 2.0 1.1  ± 0.4 0.425
AVS: aortic valvular stenosis, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL: low density lipoprotein, HDL: high 
density lipoprotein
Table 2. Echocardiographic parameters 
Mild AVS (n = 207) Moderate AVS (n = 81) Severe AVS (n = 37) p value
LV diastolic dimension (mm) 52.4  ± 6.2 51.8  ± 6.5 50.4  ± 5.3 0.175
LV systolic dimension (mm) 32.3  ± 7.8 31.6  ± 7.1 29.9  ± 4.4 0.162
LA dimension (mm) 42.5  ± 7.1 42.7 ± 7.4 40.6  ± 8.1 0.310
LV ejection fraction (%) 60.9  ± 12.1 58.4  ± 15.4 66.9  ± 4.5 0.267
LV mass index (g/m
2) 111.6  ± 32.3 121.7  ± 34.1 125.4  ± 34.5 0.013
E velocity (m/s) 0.80  ± 0.35 0.82  ± 0.33 0.75  ± 0.30 0.621
A velocity (m/s) 0.96  ± 0.29 0.99  ± 0.28 0.93  ± 0.29 0.599
E/A ratio 0.86  ± 0.56 0.82  ± 0.33 0.85  ± 0.35 0.831
Deceleration time (ms) 263.2  ± 91.3 281.8  ± 103.6 269.3  ± 63.6 0.334
BAV 14 (6.8%) 15 (18.5%) 12 (32.4%) < 0.001
Maximum aortic jet velocity 
Baseline (m/s) 2.43  ± 0.25 3.40  ± 0.29 4.64  ± 0.60 < 0.001*
Progression rate (m/s/yr) 0.09  ± 0.18 0.14  ± 0.25 0.28  ± 0.36 < 0.001*
*analyzed by Kruskal-Wallis test AVS: aortic valvular stenosis, LV: left ventricular, LA: left atrium, BAV: bicuspid aortic valvedently influenced by initial maximum aortic jet velocity (Beta
= 0.175, p = 0.003), BAV (Beta = 0.127, p = 0.029), and E
velocity (Beta = -0.134, p = 0.018). To test potential colin-
earity, Variance Inflation Factor (VIF) and tolerance for each
independent variable were estimated. There is no problem of
potential colinearity. This data is summarized in Table 4. 
D Di is sc cu us ss si io on n
Using echocardiography, previous studies have reported
the natural history of AVS.
1)3)4) However, the progression rate
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Mild AVS
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p < 0.001
p = 0.219
p = 0.006
Moderate AVS Severe AVS
Fig. 1. Progression rate of maximum aortic jet velocity according to AVS
severity. Bars, mean ± SD. A p value indicates difference between
groups based on scheffe’s multiple comparison test. AVS: aortic valvular
stenosis.
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Fig. 2. Progression rate of maximum aortic jet velocity with and without
bicuspid aortic valve. Bars, mean ±SD. AVS: aortic valvular stenosis.
Table 3. Comparison of rapid versus slow progressors of aortic valvular stenosis
Slow progressor (n = 189) Rapid progressor (n = 136) p value
Age (yr) 66  ± 13 68  ± 12 0.085
Gender (male) 105 (55.6%) 76 (55.9%) 0.953
BMI (kg/m
2) 24.5  ± 3.7 24.6  ± 3.7 0.795
SBP (mmHg) 137.2  ± 24.2 134.6  ± 22.5 0.325
DBP (mmHg) 76.2  ± 13.6 75.4  ± 12.9 0.574
Current smoking 31 (16.8%) 22 (16.4%) 0.936
Hypertension 113 (59.8%) 80 (58.8%) 0.861
Diabetes 52 (27.5%) 41 (30.1%) 0.604
Hypercholesterolemia 84 (45.4%) 60 (45.1%) 0.959
Coronary artery disease 43 (22.8%) 28 (20.6%) 0.642
Total cholesterol (mg/dL) 173.6  ± 41.3 174.6  ± 35.4 0.820
Calcium (mg/dL) 8.9  ± 0.7 9.0  ± 0.7 0.354
Creatinine (mg/dL) 1.6  ± 2.1 1.2  ± 1.4 0.088
LV diastolic dimension (mm) 52.6  ± 6.0 51.2  ± 6.5 0.052
LV systolic dimension (mm) 32.1  ± 7.2 31.4  ± 7.6 0.350
LA dimension (mm) 42.8  ± 7.1 41.7  ± 7.5 0.157
LV ejection fraction (%) 62.7  ± 10.7 59.9  ± 13.6 0.391
LV mass index (g/m
2) 116.3  ± 33.6 115.0  ± 33.1 0.733
E velocity (m/s) 0.84  ± 0.34 0.74  ± 0.33 0.018
A velocity (m/s) 0.98  ± 0.29 0.94  ± 0.28 0.205
E/A ratio 0.89  ± 0.58 0.79  ± 0.32 0.098
BAV 19 (10.1%) 22 (16.2%) 0.101
Maximum aortic jet velocity (m/s) 2.80  ± 0.70 3.09  ± 0.91 0.002
Mean transvalvular gradient (mmHg)* 17.9  ± 12.9 25.1  ± 15.7 < 0.001 0
Aortic valve area (cm
2)� 1.34  ± 0.39 1.21  ± 0.39 0.013
*slow progresor n = 154, fast progressor n = 118, �slow progressor n = 113, fast progressor n = 101. BMI: body mass index, SBP: systolic blood pressure, DBP: 
diastolic blood pressure, LV: left ventricular, LA: left atrium, BAV: bicuspid aortic valve for patients with AVS has not been fully established in Asian
population and it may differ from that the Western popula-
tion. This retrospective study has defined the rate and varia-
bility of hemodynamic progression of AVS in Korean popul-
ation and the factor associated with AVS progression. The
initial maximum aortic jet velocity, mitral E velocity, and BAV
are related to the rate of hemodynamic progression of AVS.
Rate of AVS progression
The mean progression rate of 0.12 ± 0.23 m/s/yr in this
study is substantially less than that reported in previous
studies.
1)3)4) It could be explained by the result that the initial
maximum aortic jet velocity in current study was lower than
that in previous reports (2.92 ± 0.81 m/s vs. 3.13 ± 5.0
m/s).
1)3)4) However, when the result of the previous study of
176 patients with mild and moderate AVS
4) are compared to
that of our subgroup whose initial maximum aortic jet
velocity is similar to the former study, this explanation may
not be persuasive enough. Even though initial maximum
aortic jet velocity of moderate AVS in our study is similar or
slightly higher than that of mild to moderate AVS in Rosen-
hek et al’s study (3.4 ± 0.29 m/s vs. 3.13 ± 0.39 m/s), the
progression rate of AVS in our subgroup is still less than that
in Rosenhek et al’s study (0.14 ± 0.25 m/s/yr vs. 0.24 ± 0.30
m/s/yr). The mean age of patients, which was reported to be
associated with the rate of AVS progression,
6) is rather higher
in moderate AVS patients in current study than that of mild
to moderate AVS patients in Rosenhek et al’s study (67 ± 14
yrs vs. 58 ± 19 yrs) and male proportion of patients is not
quite different in both groups (53% vs. 59%). In the Japanese
study of 41 patients with mild to moderate AVS,
13) the mean
rates of progression are 0.11 ± 0.13 m/s/yr in patients under
80 yrs and 0.11 ± 0.14 m/s/yr over 80 yrs when the mean
initial maximum aortic jet velocity was 2.95 ± 0.43 m/s and
2.52 ± 0.54 m/s, respectively. Those results are very similar
to our findings. Also, it has been reported that there were
ethnic differences in AV calcification
7)8) which play an im-
portant role in progression of AVS. Therefore, the progres-
sion rate of AVS might be different according to the ethnic
differences as well as other causes. 
The progression rate of AVS in patients with BAV we
observed is 0.23 ± 0.35 m/s/yr. It is similar to the Otto et
al.’s study,
1) where in 123 patients with AVS including 34
patients (28%) with bicuspid AVS, the progression rate of
AVS in patients with BAV was 0.24 ±0.30 m/s/yr.
Predictors of AVS progression
In our study, progression rate of AVS appeared to be more
rapid in severe AVS than in moderate and mild. Further-
more, initial maximum aortic jet velocity was one of the inde-
pendent predictors of the progression rate of AVS. The
advantage of maximum aortic jet velocity as a measure of
stenosis severity, when contractility is preserved, is that it is
recorded directly on Doppler examination, requires no struc-
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Table 4. Association between the progression rate of aortic valvular stenosis and clinical and echocardiographic parameters 
Variable
Univariate Multivariate
tr p value β p value
Age 0.065 0.239
Gender -1.200 0.231
Current smoking -0.158 0.874
Hypertension -0.064 0.249
Diabetes -0.986 0.325
Hypercholesterolemia 0.012 0.211
Coronary artery disease -1.182 0.238
Total cholesterol 0.077 0.169
Calcium 0.080 0.161
Creatinine -0.119 0.034
LV diastolic dimension -0.160 0.004
LV systolic dimension -0.081 0.148
LA dimension -0.115 0.039
LV ejection fraction -0.040 0.764
LV mass index  -0.038 0.505
E velocity -0.143 0.012 -0.134 0.018
A velocity -0.080 0.180
E/A ratio -0.085 0.153
BAV 3.2 0.001 0.127 0.029
Maximum aortic jet velocity  0.204 < 0.001 0.175 0.003
LV: left ventricular, LA: left atrium, BAV: bicuspid aortic valvetural assumptions, and has a low intra and interobserver
variability in experienced laboratories. In addition to initial
AVA, Bahler et al.
5) found the severity index composed of
valve calcification and mobility to be the independent pre-
dictors of AVS progression. In addition, Palta et al.
14) report-
ed that initial aortic valve area, smoking, and serum calcium
level were also associated with more rapid progression of
AVS. However, in present study, smoking and serum calcium
level did not appear to be associated with AVS progression.
The severity index using aortic valvular calcification was not
measured.
Our data showed that the BAV was associated with more
rapid progression of AVS. There was no significant different
of BAV between rapid progressor and slow progressor. How-
ever, in a stepwise multiple regression analysis, annual progres-
sion rate was independently influenced by BAV. This disc-
repancy would be explained by cut-off value of rapid pro-
gression. In our study, a mean increase in maximum aortic
jet velocity per year of 0.12 m/s, the patients were dichoto-
mously divided into rapid (≥ 0.12 m/s/yr) and slow progres-
sors (< 0.12 m/s/yr). Although there was no difference in
rapid and slow progressor, the progression rate of AVS was
significantly related to BAV. This might be because bicuspid
valves with asymmetrical leaflet sizes are more prone to rapid
valve degeneration which is induced by excessive hemody-
namic stress, resulting from straightening and stretching of
the leaflets when they are open and close.
15)
Interestingly, mitral E velocity is closely related to AVS
progression in our study. In patients with AVS, diastolic dys-
function defined as either abnormal relaxation, decreased
diastolic filling, or increased myocardial stiffness was observ-
ed in approximately 50% of the patients with normal systolic
ejection performance, and was found in 100% of the pati-
ents with depressed systolic function.
16) Thus, E velocity as
the factor significantly associated with AVS progression in
present study might represent diastolic dysfunction in AVS.
The reason for this finding remains uncertain although dias-
tolic dysfunction could be suggested. For better explanation,
we have to consider whole diastolic parameters such as E’
velocity, deceleration time, isovolumic relaxation time, and
E/E’ ratio. However, this is a retrospective study in a single
center. We did not collect whole diastolic parameters such as
E’ velocity, deceleration time, isovolumic relaxation time, and
E/E’ ratio in every patients. Therefore, our findings should
be verified by further well-controlled prospective study. 
Limitations
This study has several limitations. AV calcification has
been shown to be associated with more rapid progression of
AVS,
3)5) and ethnic difference in valve thickening and calcifi-
cation might elucidate the mechanism of the slow progres-
sion of AVS in current study.
7)8) Unfortunately, we did not in-
clude the grading of AV calcification by echocardiography or
the quantification of AV calcification and thickness by com-
puted tomography (CT) in this study. However, we believe
the quantitation of AV calcification by echocardiography is
not reliable enough because it depends significantly on the
machine setting, image quality and the echocardiographer’s
experience. Also, we had difficulty to do CT scan in the rou-
tine evaluation of AVS because CT scan has the risk of radia-
tion exposure. In present study, the progression rate of AVS
is slower than that in previous studies conducted in Western
population. However, it is hard to compare the progression
rate of AVS among different studies and disclose the cause of
difference in the progression rate of AVS because clinical and
echocardiographic characteristics among studies are different.
E velocity was significantly associated with AVS progression
in our study. The reason for this finding remains uncertain
although diastolic dysfunction could be suggested. For better
explanation, we have to consider whole diastolic parameters
such as E’ velocity, deceleration time, isovolumic relaxation
time, and E/E’ ratio. However, this is a retrospective study in
a single center. We did not collect whole diastolic parameters
such as E’ velocity, deceleration time, isovolumic relaxation
time, and E/E’ ratio in every patients. This is a retrospective
study in a single center. Therefore, our findings should be
verified by further well-controlled prospective study. Finally,
our study focused only on hemodynamic progression, which
is not synonymous with clinical progression.
In conclusion, this is the study to estimate the progression
rate in Korean AVS patients. In this study, AVS progresses
more rapidly in severe AVS than in moderate or mild AVS.
Also, AVS severity and BAV are associated with more rapid
progression of AVS. Comparing our results with previous
studies, the progression rate of AVS in Korean appears to be
slower than that in Western population. Therefore, ethnic
differences should be considered for the follow-up of the
patients with AVS. 
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